{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:26:14Z","timestamp":1773098774384,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00213-022-06263-w","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T04:02:54Z","timestamp":1666411374000},"page":"3919-3927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acute administration of ibuprofen increases serum concentration of the neuroprotective kynurenine pathway metabolite, kynurenic acid: a pilot randomized, placebo-controlled, crossover study"],"prefix":"10.1007","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8143-182X","authenticated-orcid":false,"given":"Jonathan","family":"Savitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart N.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayus","family":"Kuplicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahib","family":"Khalsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Kent","family":"Teague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin P.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,22]]},"reference":[{"key":"6263_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","volume":"159","author":"LZ Agudelo","year":"2014","unstructured":"Agudelo LZ, Femenia T, Orhan F, Porsmyr-Palmertz M, Goiny M et al (2014) Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159:33\u201345","journal-title":"Cell"},{"key":"6263_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15:1257\u20131272","journal-title":"Lancet Neurol"},{"key":"6263_CR3","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/s41380-020-00913-1","volume":"26","author":"F Bartoli","year":"2021","unstructured":"Bartoli F, Misiak B, Callovini T, Cavaleri D, Cioni RM et al (2021) The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites. Mol Psychiatry 26:3419\u20133429","journal-title":"Mol Psychiatry"},{"key":"6263_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","volume":"43","author":"C Bay-Richter","year":"2015","unstructured":"Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Traskman-Bendz L et al (2015) A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality. Brain Behav Immun 43:110\u2013117","journal-title":"Brain Behav Immun"},{"key":"6263_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12916-019-1475-6","volume":"18","author":"M Berk","year":"2020","unstructured":"Berk M, Mohebbi M, Dean OM, Cotton SM, Chanen AM et al (2020) Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin. BMC Med 18:16","journal-title":"BMC Med"},{"key":"6263_CR6","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/jamapsychiatry.2020.1214","volume":"77","author":"M Berk","year":"2020","unstructured":"Berk M, Woods RL, Nelson MR, Shah RC, Reid CM et al (2020) Effect of aspirin vs placebo on the prevention of depression in older people: a randomized clinical trial. JAMA Psychiat 77:1012\u20131020","journal-title":"JAMA Psychiat"},{"key":"6263_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41598-022-04875-y","volume":"12","author":"K Burrows","year":"2022","unstructured":"Burrows K, Figueroa-Hall LK, Kuplicki R, Stewart JL, Alarbi AM et al (2022) Neuronally-enriched exosomal microRNA-27b mediates acute effects of ibuprofen on reward-related brain activity in healthy adults: a randomized, placebo-controlled, double-blind trial. Sci Rep 12:861","journal-title":"Sci Rep"},{"key":"6263_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.mp.4000995","volume":"7","author":"L Capuron","year":"2002","unstructured":"Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M et al (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468\u2013473","journal-title":"Mol Psychiatry"},{"key":"6263_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbi.2021.05.023","volume":"96","author":"KT Cosgrove","year":"2021","unstructured":"Cosgrove KT, Kuplicki R, Savitz J, Burrows K, Simmons WK et al (2021) Impact of ibuprofen and peroxisome proliferator-activated receptor gamma on emotion-related neural activation: a randomized, placebo-controlled trial. Brain Behav Immun 96:135\u2013142","journal-title":"Brain Behav Immun"},{"key":"6263_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O\u2019Connor JC, Lawson MA, Kelley KW (2011) Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36:426\u2013436","journal-title":"Psychoneuroendocrinology"},{"key":"6263_CR11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/j.1471-4159.1991.tb06359.x","volume":"57","author":"AJ Dunn","year":"1991","unstructured":"Dunn AJ, Welch J (1991) Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J Neurochem 57:1615\u20131622","journal-title":"J Neurochem"},{"key":"6263_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1211\/0022357001773698","volume":"52","author":"SR Edwards","year":"2000","unstructured":"Edwards SR, Mather LE, Lin Y, Power I, Cousins MJ (2000) Glutamate and kynurenate in the rat central nervous system following treatments with tail ischaemia or diclofenac. J Pharm Pharmacol 52:59\u201366","journal-title":"J Pharm Pharmacol"},{"key":"6263_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/npp.2012.248","volume":"38","author":"S Erhardt","year":"2013","unstructured":"Erhardt S, Lim CK, Linderholm KR, Janelidze S, Lindqvist D et al (2013) Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38:743\u2013752","journal-title":"Neuropsychopharmacology"},{"key":"6263_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","volume":"76","author":"X Gao","year":"2011","unstructured":"Gao X, Chen H, Schwarzschild MA, Ascherio A (2011) Use of ibuprofen and risk of Parkinson disease. Neurology 76:863\u2013869","journal-title":"Neurology"},{"key":"6263_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2015.02.029","volume":"48","author":"S Guloksuz","year":"2015","unstructured":"Guloksuz S, Arts B, Walter S, Drukker M, Rodriguez L et al (2015) The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway. Brain Behav Immun 48:48\u201352","journal-title":"Brain Behav Immun"},{"key":"6263_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","volume":"66\u201367","author":"A Halaris","year":"2015","unstructured":"Halaris A, Myint AM, Savant V, Meresh E, Lim E et al (2015) Does escitalopram reduce neurotoxicity in major depression? J Psychiatr Res 66\u201367:118\u2013126","journal-title":"J Psychiatr Res"},{"key":"6263_CR17","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/mds.28202","volume":"35","author":"PL Heilman","year":"2020","unstructured":"Heilman PL, Wang EW, Lewis MM, Krzyzanowski S, Capan CD et al (2020) Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson\u2019s disease. Mov Disord 35:2028\u20132037","journal-title":"Mov Disord"},{"key":"6263_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12916-020-01709-4","volume":"18","author":"K Hu","year":"2020","unstructured":"Hu K, Sjolander A, Lu D, Walker AK, Sloan EK et al (2020) Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study. BMC Med 18:238","journal-title":"BMC Med"},{"key":"6263_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","volume":"7","author":"MI Husain","year":"2020","unstructured":"Husain MI, Chaudhry IB, Khoso AB, Husain MO, Hodsoll J et al (2020) Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial. Lancet Psychiatry 7:515\u2013527","journal-title":"Lancet Psychiatry"},{"issue":"1017","key":"6263_CR20","first-page":"e11","volume":"126","author":"RL Iyengar","year":"2013","unstructured":"Iyengar RL, Gandhi S, Aneja A, Thorpe K, Razzouk L et al (2013) NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med 126(1017):e11\u2013e18","journal-title":"Am J Med"},{"key":"6263_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2021.04.020","volume":"96","author":"F Javelle","year":"2021","unstructured":"Javelle F, Bloch W, Knoop A, Guillemin GJ, Zimmer P (2021) Toward a neuroprotective shift: eight weeks of high intensity interval training reduces the neurotoxic kynurenine activity concurrently to impulsivity in emotionally impulsive humans - a randomized controlled trial. Brain Behav Immun 96:7\u201317","journal-title":"Brain Behav Immun"},{"key":"6263_CR22","doi-asserted-by":"publisher","unstructured":"Kadriu B, Farmer CA, Yuan P, Park LT, Deng ZD, Moaddel R, Henter ID, Shovestul B, Ballard ED, Kraus C, Gold PW, Machado-Vieira R, Zarate CA Jr (2021) The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response. Mol Psychiatry 26(8):4085\u20134095. https:\/\/doi.org\/10.1038\/s41380-019-0589-8","DOI":"10.1038\/s41380-019-0589-8"},{"key":"6263_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/WNF.0000000000000448","volume":"44","author":"L Kapulsky","year":"2021","unstructured":"Kapulsky L, Christos P, Ilagan J, Kocsis J (2021) The effects of ibuprofen consumption on the incidence of postpartum depression. Clin Neuropharmacol 44:117\u2013122","journal-title":"Clin Neuropharmacol"},{"key":"6263_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/acps.12957","volume":"139","author":"LV Kessing","year":"2019","unstructured":"Kessing LV, Rytgaard HC, Gerds TA, Berk M, Ekstrom CT et al (2019) New drug candidates for depression - a nationwide population-based study. Acta Psychiatr Scand 139:68\u201377","journal-title":"Acta Psychiatr Scand"},{"key":"6263_CR25","doi-asserted-by":"publisher","first-page":"e00338","DOI":"10.1002\/brb3.338","volume":"5","author":"O Kohler","year":"2015","unstructured":"Kohler O, Petersen L, Mors O, Gasse C (2015) Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes. Brain Behav 5:e00338","journal-title":"Brain Behav"},{"key":"6263_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/acps.13016","volume":"139","author":"O Kohler-Forsberg","year":"2019","unstructured":"Kohler-Forsberg O, Lydholm CN, Hjorthoj C, Nordentoft M, Mors O et al (2019) Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand 139:404\u2013419","journal-title":"Acta Psychiatr Scand"},{"key":"6263_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","volume":"1","author":"IP Lapin","year":"1969","unstructured":"Lapin IP, Oxenkrug GF (1969) Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1:132\u2013136","journal-title":"Lancet"},{"key":"6263_CR28","first-page":"205","volume":"28","author":"S Lehrer","year":"2019","unstructured":"Lehrer S, Rheinstein PH (2019) Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce suicidal ideation and depression. Discov Med 28:205\u2013212","journal-title":"Discov Med"},{"key":"6263_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","volume":"155","author":"CK Lim","year":"2017","unstructured":"Lim CK, Fernandez-Gomez FJ, Braidy N, Estrada C, Costa C et al (2017) Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease. Prog Neurobiol 155:76\u201395","journal-title":"Prog Neurobiol"},{"key":"6263_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuroscience.2012.12.052","volume":"234","author":"P Maciejak","year":"2013","unstructured":"Maciejak P, Szyndler J, Turzynska D, Sobolewska A, Kolosowska K et al (2013) The kynurenine pathway: a missing piece in the puzzle of valproate action? Neuroscience 234:135\u2013145","journal-title":"Neuroscience"},{"key":"6263_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2215\/CJN.05240418","volume":"14","author":"M Madero","year":"2019","unstructured":"Madero M, Cano KB, Campos I, Tao X, Maheshwari V et al (2019) Removal of protein-bound uremic toxins during hemodialysis using a binding competitor. Clin J Am Soc Nephrol 14:394\u2013402","journal-title":"Clin J Am Soc Nephrol"},{"key":"6263_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","volume":"42","author":"M Modoux","year":"2021","unstructured":"Modoux M, Rolhion N, Mani S, Sokol H (2021) Tryptophan metabolism as a pharmacological target. Trends Pharmacol Sci 42:60\u201373","journal-title":"Trends Pharmacol Sci"},{"key":"6263_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61:519\u2013525","journal-title":"Med Hypotheses"},{"key":"6263_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","volume":"98","author":"AM Myint","year":"2007","unstructured":"Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H et al (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98:143\u2013151","journal-title":"J Affect Disord"},{"key":"6263_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.lfs.2015.10.020","volume":"143","author":"DM Norden","year":"2015","unstructured":"Norden DM, McCarthy DO, Bicer S, Devine RD, Reiser PJ et al (2015) Ibuprofen ameliorates fatigue- and depressive-like behavior in tumor-bearing mice. Life Sci 143:65\u201370","journal-title":"Life Sci"},{"key":"6263_CR36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Moreau M, Lestage J et al (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511\u2013522","journal-title":"Mol Psychiatry"},{"key":"6263_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","volume":"101","author":"ER Paul","year":"2022","unstructured":"Paul ER, Schwieler L, Erhardt S, Boda S, Trepci A et al (2022) Peripheral and central kynurenine pathway abnormalities in major depression. Brain Behav Immun 101:136\u2013145","journal-title":"Brain Behav Immun"},{"key":"6263_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pbb.2014.07.013","volume":"125","author":"LA Saleh","year":"2014","unstructured":"Saleh LA, Hamza M, El Gayar NH, Abd El-Samad AA, Nasr EA et al (2014) Ibuprofen suppresses depressive like behavior induced by BCG inoculation in mice: role of nitric oxide and prostaglandin. Pharmacol Biochem Behav 125:29\u201339","journal-title":"Pharmacol Biochem Behav"},{"key":"6263_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25:131\u2013147. https:\/\/doi.org\/10.1038\/s41380-019-0414-4","journal-title":"Mol Psychiatry"},{"key":"6263_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.bbi.2022.01.021","volume":"101","author":"J Savitz","year":"2022","unstructured":"Savitz J (2022) Blood versus cerebrospinal fluid: kynurenine pathway metabolites in depression. Brain Behav Immun 101:333\u2013334","journal-title":"Brain Behav Immun"},{"key":"6263_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/npp.2014.194","volume":"40","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Smith CM, Victor TA, Wurfel BE et al (2015) Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 40:463\u2013471","journal-title":"Neuropsychopharmacology"},{"key":"6263_CR42","unstructured":"Savitz J, Ford BN, Yeh HW, Akeman E, Cosgrove K et al (2020) Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid. Psychol Med 1\u201310"},{"key":"6263_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","volume":"8","author":"JB Savitz","year":"2018","unstructured":"Savitz JB, Teague TK, Misaki M, Macaluso M, Wurfel BE et al (2018) Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2x2 double-blind, randomized, placebo-controlled, phase IIA clinical trial. Transl Psychiatry 8:27","journal-title":"Transl Psychiatry"},{"key":"6263_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1126\/science.156.3771.21","volume":"156","author":"JJ Schildkraut","year":"1967","unstructured":"Schildkraut JJ, Kety SS (1967) Biogenic amines and emotion. Science 156:21\u201337","journal-title":"Science"},{"key":"6263_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465\u2013477","journal-title":"Nat Rev Neurosci"},{"key":"6263_CR46","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00702-004-0231-y","volume":"112","author":"L Schwieler","year":"2005","unstructured":"Schwieler L, Erhardt S, Erhardt C, Engberg G (2005) Prostaglandin-mediated control of rat brain kynurenic acid synthesis\u2013opposite actions by COX-1 and COX-2 isoforms. J Neural Transm (vienna) 112:863\u2013872","journal-title":"J Neural Transm (vienna)"},{"key":"6263_CR47","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/syn.20241","volume":"59","author":"L Schwieler","year":"2006","unstructured":"Schwieler L, Erhardt S, Nilsson L, Linderholm K, Engberg G (2006) Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons\u2013possible involvement of endogenous kynurenic acid. Synapse 59:290\u2013298","journal-title":"Synapse"},{"key":"6263_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","volume":"13","author":"L Schwieler","year":"2016","unstructured":"Schwieler L, Samuelsson M, Frye MA, Bhat M, Schuppe-Koistinen I et al (2016) Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. J Neuroinflammation 13:51","journal-title":"J Neuroinflammation"},{"key":"6263_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2018.12.033","volume":"696","author":"MK Seo","year":"2019","unstructured":"Seo MK, Lee JG, Park SW (2019) Effects of escitalopram and ibuprofen on a depression-like phenotype induced by chronic stress in rats. Neurosci Lett 696:168\u2013173","journal-title":"Neurosci Lett"},{"key":"6263_CR50","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1021\/acsomega.7b02091","volume":"3","author":"S Shave","year":"2018","unstructured":"Shave S, McGuire K, Pham NT, Mole DJ, Webster SP et al (2018) Diclofenac Identified as a Kynurenine 3-Monooxygenase Binder and Inhibitor by Molecular Similarity Techniques. ACS Omega 3:2564\u20132568","journal-title":"ACS Omega"},{"key":"6263_CR51","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/jnc.14843","volume":"151","author":"FJH Sorgdrager","year":"2019","unstructured":"Sorgdrager FJH, Vermeiren Y, Van Faassen M, van der Ley C, Nollen EAA et al (2019) Age- and disease-specific changes of the kynurenine pathway in Parkinson\u2019s and Alzheimer\u2019s disease. J Neurochem 151:656\u2013668","journal-title":"J Neurochem"},{"key":"6263_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1742-2094-8-94","volume":"8","author":"J Steiner","year":"2011","unstructured":"Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG et al (2011) Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8:94","journal-title":"J Neuroinflammation"},{"key":"6263_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.plefa.2009.10.007","volume":"82","author":"P Stolk","year":"2010","unstructured":"Stolk P, Souverein PC, Wilting I, Leufkens HG, Klein DF et al (2010) Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids 82:9\u201314","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"6263_CR54","doi-asserted-by":"publisher","first-page":"102559","DOI":"10.1016\/j.nicl.2021.102559","volume":"29","author":"A Tsuchiyagaito","year":"2021","unstructured":"Tsuchiyagaito A, Smith JL, El-Sabbagh N, Zotev V, Misaki M et al (2021) Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder. Neuroimage Clin 29:102559","journal-title":"Neuroimage Clin"},{"key":"6263_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bbi.2019.06.033","volume":"81","author":"F Verdonk","year":"2019","unstructured":"Verdonk F, Petit AC, Abdel-Ahad P, Vinckier F, Jouvion G et al (2019) Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine. Brain Behav Immun 81:361\u2013373","journal-title":"Brain Behav Immun"},{"key":"6263_CR56","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1073\/pnas.1104836108","volume":"108","author":"JL Warner-Schmidt","year":"2011","unstructured":"Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011) Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A 108:9262\u20139267","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6263_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/sj.mp.4001600","volume":"10","author":"MC Wichers","year":"2005","unstructured":"Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S et al (2005) IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 10:538\u2013544","journal-title":"Mol Psychiatry"},{"key":"6263_CR58","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","volume":"16","author":"B Widner","year":"2002","unstructured":"Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D (2002) Neopterin production, tryptophan degradation, and mental depression\u2013what is the link? Brain Behav Immun 16:590\u2013595","journal-title":"Brain Behav Immun"},{"key":"6263_CR59","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1038\/tp.2017.88","volume":"7","author":"BE Wurfel","year":"2017","unstructured":"Wurfel BE, Drevets WC, Bliss SA, McMillin JR, Suzuki H et al (2017) Serum kynurenic acid is reduced in affective psychosis. Transl Psychiatry 7:e1115","journal-title":"Transl Psychiatry"},{"key":"6263_CR60","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1007\/s12035-015-9355-3","volume":"53","author":"T Yagami","year":"2016","unstructured":"Yagami T, Koma H, Yamamoto Y (2016) Pathophysiological roles of cyclooxygenases and prostaglandins in the central nervous system. Mol Neurobiol 53:4754\u20134771","journal-title":"Mol Neurobiol"},{"key":"6263_CR61","doi-asserted-by":"publisher","first-page":"106024","DOI":"10.1016\/j.phrs.2021.106024","volume":"175","author":"L Zhang","year":"2022","unstructured":"Zhang L, Bao Y, Tao S, Zhao Y, Liu M (2022) The association between cardiovascular drugs and depression\/anxiety in patients with cardiovascular disease: a meta-analysis. Pharmacol Res 175:106024","journal-title":"Pharmacol Res"},{"key":"6263_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbi.2022.07.011","volume":"105","author":"H Zheng","year":"2022","unstructured":"Zheng H, Teague TK, Yeh FC, Burrows K, Figueroa-Hall LK et al (2022) C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder. Brain Behav Immun 105:180\u2013189","journal-title":"Brain Behav Immun"},{"key":"6263_CR63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2018.09.007","volume":"74","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zheng W, Liu W, Wang C, Zhan Y et al (2018) Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression. Brain Behav Immun 74:205\u2013212","journal-title":"Brain Behav Immun"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06263-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T11:09:22Z","timestamp":1668769762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06263-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,22]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6263"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06263-w","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,22]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}